A5026421426- Renal Diseases and Glomerulopathies
- Liver Disease and Transplantation
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Diabetes Treatment and Management
- Renal Transplantation Outcomes and Treatments
- Bone health and treatments
- Muscle and Compartmental Disorders
- Liver Disease Diagnosis and Treatment
- Potassium and Related Disorders
- Bone and Joint Diseases
- Mechanical Circulatory Support Devices
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Renal and Vascular Pathologies
- Parathyroid Disorders and Treatments
- Chronic Lymphocytic Leukemia Research
- Cancer Diagnosis and Treatment
- Cardiac Arrest and Resuscitation
- Renal function and acid-base balance
- Electrolyte and hormonal disorders
- Adrenal and Paraganglionic Tumors
- Retinal and Optic Conditions
- Vasculitis and related conditions
- Pituitary Gland Disorders and Treatments
- Pharmacological Effects and Toxicity Studies
The University of Queensland
2021-2025
Ochsner Health System
2022-2025
Ochsner Medical Center
2020-2024
University of New Orleans
2023-2024
University of Mississippi Medical Center
2019-2021
Jackson Memorial Hospital
2019-2021
Mayo Clinic
2021
University of Arizona
2021
Colorado Kidney Care
2021
University of Arkansas for Medical Sciences
2020-2021
AKI is commonly encountered in patients with decompensated cirrhosis, and it associated unfavorable outcomes. Among factors specific to hepatorenal syndrome type 1, also referred as syndrome-AKI, the most salient unique etiology. Patients cirrhosis are vulnerable traditional causes of AKI, such prerenal azotemia, acute tubular injury, interstitial nephritis. In addition, other less common etiologies specifically related chronic liver disease should be considered, including abdominal...
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are FDA-approved for weight loss and increasingly prescribed patients with obesity type 2 diabetes mellitus. Multiple studies have demonstrated desirable renal cardiovascular benefits from these novel agents. So far, a few case reports of acute tubular injury interstitial nephritis been reported GLP-1RA. Podocytopathies in association semaglutide rare. In this report, we present nephrotic syndrome that developed after...
Journal Article Accepted manuscript Recovery from acute kidney injury treated with dialysis in patients multiple myeloma proteasome inhibitors Get access Swetha R Kanduri, Kanduri Department of Nephrology, Ochsner Health, New Orleans, LA, USAOchsner Clinical School, The University Queensland, Brisbane, Australia Correspondence to: R. Kanduri; E-mail: [email protected] https://orcid.org/0000-0002-7190-6665 Search for other works by this author on: Oxford Academic PubMed Google Scholar Ambuga...
Background: Reports on the performance of glomerular hematuria for diagnosis glomerulonephritis (GN) show heterogeneity in results and used urological pathologies as controls. We hypothesized that identification urinary acanthocytes (uACANTHO) and/or red blood cell casts (uRBCC) by comprehensive microscopic examination sediment (uMICRO) can differentiate disease from non-glomerular renal pathology. Methods: Records patients seen consultation acute kidney injury or proteinuria/hematuria who...
Immunotherapy has grown significantly in the management of hematological and solid organ tumors. In-depth knowledge T-cell pathways led to development adoptive cell transfer techniques subsequent evolution chimeric antigen receptor (CAR-T) therapies.1Gill S. Maus M.V. Porter D.L. Chimeric T therapy: 25 years making.Blood Rev. 2016; 30: 157-167Crossref PubMed Scopus (136) Google Scholar CAR-T cells are biologically engineered with a CAR that recognizes tumor antigen. receptors equipped...
Key Points Raising the mean arterial pressure (MAP) during management of hepatorenal syndrome type 1 (HRS-1) is associated with improvement in kidney function, independently baseline MAP or model for end-stage liver disease. by 15 mm Hg greater leads to reduction serum creatinine HRS-1. Norepinephrine use confers probability function HRS-1 compared midodrine/octreotide. Background treatment vasoconstrictors (VCs) renal recovery. However, optimal target and factors response VCs remain...
A 21-year-old male patient presented to the endocrine clinic with a history of congenital hypopituitarism. He had adrenal insufficiency, hypothyroidism and hypogonadism, which were being adequately replaced. At age 4, he was brought failure thrive small stature.
Background The objective of this study was to evaluate the predictors and associated outcomes rhabdomyolysis in admitted patients for heat stroke United States.Methods National Inpatient Sample utilized identify hospitalized with a primary diagnosis from years 2003–2014. Rhabdomyolysis identified using hospital code. We compared clinical characteristics, in-hospital treatment, complications, outcomes, resource utilization between without rhabdomyolysis.Results A total 3,372 admissions were...
Hepatorenal syndrome (HRS) is a life-threatening condition among patients with advanced liver disease. Data trends specific to hospital mortality and admission resource utilization for HRS remain limited.To assess the temporal trend in identify predictors admissions United States.We used National Inpatient Sample database an unweighted sample of 4938 from 2005 2014 (weighted 23973 admissions). The primary outcomes were as well mortality. We estimated odds ratios multi-level mixed effect...
The objective of this study was to describe inpatient prevalence, characteristics, outcomes, and resource use for acute salicylate intoxication hospitalizations in the United States. A total 13,805 admissions with a primary diagnosis from 2003 2014 National Inpatient Sample database were analyzed. Prognostic factors in-hospital mortality determined using multivariable logistic regression. overall prevalence among hospitalized patients 147.8 cases per 1,000,000 average age 34 ± 19 years. Of...